Alto Neuroscience
Clinical trials sponsored by Alto Neuroscience, explained in plain language.
-
New hope for tough depression: ALTO-207 trial launches
Symptom relief Recruiting nowThis study tests an experimental drug called ALTO-207 in 178 adults whose depression has not improved with at least 2 to 5 previous treatments. Participants continue their current antidepressants and receive either ALTO-207 or a placebo. The main goal is to see if ALTO-207 reduce…
Phase: PHASE2 • Sponsor: Alto Neuroscience • Aim: Symptom relief
Last updated May 01, 2026 16:09 UTC
-
New patch aims to sharpen minds in schizophrenia
Symptom relief Recruiting nowThis study tests an experimental drug called ALTO-101, given as a skin patch, to see if it can improve cognitive problems like memory and attention in people with schizophrenia. About 82 adults with stable schizophrenia and cognitive impairment will receive either the drug or a p…
Phase: PHASE2 • Sponsor: Alto Neuroscience • Aim: Symptom relief
Last updated Apr 26, 2026 20:02 UTC